These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 15742436

  • 1. Studies of serum C-reactive protein in systemic lupus erythematosus.
    Williams RC, Harmon ME, Burlingame R, Du Clos TW.
    J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436
    [Abstract] [Full Text] [Related]

  • 2. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
    Williams RC, Malone CC, Meyers C, Decker P, Muller S.
    J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
    [Abstract] [Full Text] [Related]

  • 3. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 4. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM, Vargas-Hitos J, Zamora-Pasadas M, Mediavilla JD, Navarrete N, Ramirez A, Hidalgo-Tenorio C, Jáimez L, Martín J, Jiménez-Alonso J, Grupo Lupus Virgen de las Nieves.
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [Abstract] [Full Text] [Related]

  • 5. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
    Bakri Hassan A, Rönnelid J, Gunnarsson I, Karlsson G, Berg L, Lundberg I.
    J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936
    [Abstract] [Full Text] [Related]

  • 6. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus.
    Soyfoo MS, Roth J, Vogl T, Pochet R, Decaux G.
    J Rheumatol; 2009 Oct; 36(10):2190-4. PubMed ID: 19755614
    [Abstract] [Full Text] [Related]

  • 7. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E.
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [Abstract] [Full Text] [Related]

  • 8. Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide.
    Hrycek A, Pochopień-Kenig G, Scieszka J.
    Autoimmunity; 2007 May; 40(3):217-22. PubMed ID: 17453721
    [Abstract] [Full Text] [Related]

  • 9. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE, Sturgess AD, Davies MJ.
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [Abstract] [Full Text] [Related]

  • 10. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis.
    Gabay C, Roux-Lombard P, de Moerloose P, Dayer JM, Vischer T, Guerne PA.
    J Rheumatol; 1993 May; 20(5):815-21. PubMed ID: 8336307
    [Abstract] [Full Text] [Related]

  • 11. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
    Su Y, Jia RL, Han L, Li ZG.
    Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
    [Abstract] [Full Text] [Related]

  • 12. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
    O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A.
    Arthritis Rheum; 2010 Mar; 62(3):845-54. PubMed ID: 20131231
    [Abstract] [Full Text] [Related]

  • 13. Antibody clustering helps refine lupus prognosis.
    Kessel A, Rosner I, Halasz K, Grushko G, Shoenfeld Y, Paran D, Toubi E.
    Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
    [Abstract] [Full Text] [Related]

  • 14. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E.
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [Abstract] [Full Text] [Related]

  • 15. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A, Cheung BM, Mok CC, Leung R, Lau CS.
    Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
    [Abstract] [Full Text] [Related]

  • 16. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus.
    Rovenský J, Juránková E, Rauová L, Blazícková S, Lukác J, Veselková Z, Jezová D, Vigas M.
    J Rheumatol; 1997 Dec; 24(12):2330-4. PubMed ID: 9415637
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT.
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.
    Sjöwall C, Bengtsson AA, Sturfelt G, Skogh T.
    Arthritis Res Ther; 2004 Apr; 6(2):R87-94. PubMed ID: 15059271
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
    Heshmat NM, El-Kerdany TH.
    Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
    [Abstract] [Full Text] [Related]

  • 20. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
    Bijl M, Bootsma H, Van Der Geld Y, Limburg PC, Kallenberg CG, Van Rijswijk MH.
    Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.